Drug Abuse and Addiction in Medical Illness:: Causes, Consequences, and Treatment

It is the expectation of the editors that this volume will become a gold standard book -- the only singular source of current and cutting-edge information for all those working with drug abusing or addicted patients or for those interested in this topic from other research perspectives. In brief, Drug Abuse and Addiction in Medical Illness: Causes, Consequences, and Treatment, will contain 62 chapters covering drugs of abuse and how they play a role in a wide range of medical illnesses. That is, the volume will discuss how, for some diseases, drug abuse will cause or enhance the progress of that disease/disorder, while other diseases may result in or enhance drug abuse. The chapters in that section will thus deal with this crucial, bi-directional relationship. Leading experts in the field of addiction throughout the world will contribute to the volume. This means the designed content will cover virtually every core, as well as contemporary, topic in the subject area, from the established theories to the most modern research and development in the field of drug abuse and addiction. Thus, once completed, the volume will be a first of its kind book, rich yet comprehensive and focused (specifically to the designated area), and will address the needs of the very active theoretical, basic, and clinical research in the field.

Here is a vital source of information for those working with drug abusing or addicted patients, with 62 chapters on drugs of abuse and their bi-directional role in illnesses. Coverage extends from established theory to the latest research and development.

INTRODUCTION [The chapters in this section will give a general overview of the causes, vulnerability and risk factors for drug abuse and addiction]1. Drug abuse, dependence and addiction
Koob GF
Department of Neuropharmacology, CVN-7, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
gkoob@scripps.edu
2. Epidemiology and trends in drug abuse
McCambridge J
National Addiction Centre, Institute of Psychiatry, King's College London, London, UK. J.McCambridge@iop.kcl.ac.uk
3. Brain reward system and compulsive drug use
Kenny PJ
Department of Biochemistry, The Scripps Research Institute, Jupiter, FL 33458, USA. pjkenny@scripps.edu
4. Genetic vulnerability for Drug Abuse and Addiction
G Uhl
Molecular Neurobiology Branch, National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, Baltimore, Maryland, USA. guhl@intra.nida.nih.gov
5. Adolescent brain development and vulnerability for addiction
Crews F
Bowles Center for Alcohol Studies, School of Medecine, University of North Carolina at Chapel Hill, NC 27599, USA.
ftcrews@med.unc.edu
6. Personality risk factors for drug abuse and addiction
Conrod PJ
Department of Psychological Medicine and Psychiatry, Section of Addiction, King's College London, University of London, London, UK.
p.conrod@iop.kcl.ac.uk
7. Automatic and controlled processes in the pathway from drug abuse to addiction
Wiers R
Experimental Psychology, Maastricht University, Maastricht, The Netherlands. r.wiers@psychology.unimaas.nl
8. Pharmacological treatment of drug abuse and addiction in medical illness
Tiet QQ
Center for Health Care Evaluation, VA Palo Alto Health Care System, Palo Alto, California 94025, USA.
Tietq2@yahoo.com
9. Psychological interventions for drug abuse and addiction
Brunette MF
Department of Psychiatry, Dartmouth Medical School, Hanover, NH 03301, USA. maryfbrunette@dartmouth.edu
10. Drug abuse and addiction in adolescents
Deas D
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC 29417, USA.
deasd@musc.edu
11. Drug abuse and addiction in elderly
Simoni-Wastila L
Long-term Care Initiative, Peter Lamy Center on Drug Therapy and Aging, School of Pharmacy, University of Maryland Baltimore, Baltimore, Maryland 21201, USA. lsimoniw@rx.umaryland.edu
DRUGS OF ABUSE AND ADDICTION [The following chapters are intended to describe generally the mechanism of action, use and abuse of these drugs, consequences (daily life, cognitive performance), and the relationship between their use and medical illness]12. Alcohol
Sher KJ
Department of Psychological Sciences, University of Missouri-Columbia, Columbia, MO 65211, USA.
sherk@missouri.edu
13. Nicotine
Mucha L
Pharmaceutical Outcomes Research, Thomson Medstat, 150 Cambridge Park Drive, Cambridge, MA 02140, USA.
Lisa.mucha@thomson.com
14. Cannabis
Di Forti M
Division of Psychological Medicine, Institute of Psychiatry, London, UK. m.diforti@iop.kcl.ac.uk
15. Cocaine
Kalivas PW
Department of Neurosciences, Medical University of South Carolina. Charleston, South Carolina 29425, USA.
kalivasp@musc.edu
16. Ecstasy and LSD
Nichols DE
Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, IN 47907-2091, USA. david.e.nichols.l@purdue.edu
17. Methamphetamine
Barr AL
Centre for Complex Disorders, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.
albarr@interchange.ubc.ca
18. GHB
Anderson IB
California Poison Control System, Department of Clinical Pharmacy, University of California, San Francisco, CA, USA.
iba@calpoison.org
19. Herbal drugs of abuse
Richardson WH, Department of Emergency Medicine, Palmetto Health Richland, 3 Medical Park, Columbia, SC 29203, USA.
whrichardson@sc.rr.com
20. Inhalants
Wu LT
Center for Risk Behavior and Mental Health Research, RTI International,